Examine This Report on LDN-27219 potential therapeutic applications
Just one specially exciting compound is LDN-27219. Although most tTG inhibitors are created to bind towards the protein crosslinking Energetic website, LDN-27219 instead binds to your nucleotide binding pocket on the enzyme whilst it is actually in its closed-condition conformation, and stabilizes that conformation to prevent crosslinking activity.